Introduction P henylketonuria (PKU) is the most prevalent disorder of amino acid metabolism, with a frequency of 1 in 10,000 Caucasians and 1 in 16,500 in Orientals, and is caused by a defect in the hepatic enzyme phenylalanine hydroxylase (PAH) (Scriver et al., 1995) .
PAH catalyses the irreversible hydroxylation of phenylalanine to tyrosine and, when defective, leads to mental retardation because of the accumulation of phenylalanine. Low-phenylalanine dietary treatment prevents this effect if it is implemented at an early age, which has led to the establishment of neonatal screening programs worldwide. More than 500 disease-causing mutations in the PAH gene have so far been identified and are recorded in the PAH Mutation Analysis Consortium database (http:==data.mch.mcgill.ca= pahdb_new=). Significant variation in the spectrum and prevalence rates of mutations in the PAH gene in different populations makes it important to define the PKU mutation profile in different distinct populations. Determination of mutation spectrum in Iranian Azeri Turkish patients may provide the design and early implementation of a patientrational dietary regimen and facilitate genetic counseling in this ethnic group. Here, the molecular characterization of the PAH genes from Iranian Azeri Turkish PKU patients is reported.
Subjects and Methods

Patients
A total of 44 unrelated families with PAH deficiency with Azeri Turkish ethnic origin, corresponding to 88 independent alleles, were enrolled in this study. Phenotypes were defined on the basis of dietary phenylalanine tolerance and pretreatment blood phenylalanine levels (Gü ttler, 1980) . Consanguinity among parents was proven in 30 (68%) cases.
Most samples reported in this study are from patients with classical PKU, which was detected after presentation of symptoms.
Mutation analysis
Each family was informed about the study and a written informed consent was obtained. Genomic DNA was extracted from peripheral blood leukocytes according to standard protocols (Miller et al., 1988) . Thirteen genomic fragments covering the entire coding sequence and the exon-flanking intron sequences of the PAH gene were amplified by polymerase chain reaction followed by single strand conformation polymorphism (SSCP) and subsequent direct sequence analysis (Santana da Silva et al., 2003) . Some common mutations were confirmed by different methods such as restriction fragment length polymorphism and amplification refractory mutation system analysis if available (Eiken et al., 1991) . The Mendelian inheritance was confirmed when possible by different methods and it was confirmed that all the mutations observed in the patients were inherited from their parents and the possibility of new mutations was excluded.
Results
Thirteen different mutations were detected on 66 of the 88 mutant alleles (diagnostic efficiency of 75%). These included six missense mutations (46%), four splice mutations (31%), two nonsense mutations (15%), and one deletion (8%) ( Table 1) . The two most common PKU mutations IVS10-11G>A and P281L accounted for more than 50% of mutant alleles. These results demonstrate that the PKU in this cohort is relatively homogeneous. Of the 44 unrelated families studied, 3 (6.8%) showed compound heterozygous mutant alleles, 26 (59.1%) were homozygotes (20 of them belonging to consanguineous families), 8 (18.2%) heterozygotes (only one mutant allele identified), and no PKU-causing mutations were detected in the remaining 7 families (16%). The following polymorphisms were observed in the PAH gene: V245V, IVS2þ19 T>C, and L385L, with the frequencies of 6.8%, 5.7%, and 2.3%, respectively (Table 2 ). Genotypes of 44 PKU patients from this cohort are shown in Table 3 .
Discussion
The 15-20 million Azeri Turks living in northwestern Iran, ethnically identical to Azeris and closely related to Turks, are believed to constitute 25% of the population. This is the first report about the mutation spectrum of the PAH gene in this ethnic group.
Analysis of the homozygosity of the mutations indicated that 59.1% (26=44) of the patients were homozygous and 25% (11=44) were heterozygous (8 heterozygotes and 3 compound heterozygotes) for the mutations that they carry. The high frequency of homozygosity, especially for rare mutations, can be explained by the high consanguinity (68%) and it is in agreement with what was found in other populations from Eastern and Central Europe (Pronina et al., 2003) .
The most common Iranian Azeri Turkish mutations, IVS10-11G>A and P281L, account for more than 50% of the identified mutations. The relative predominance of IVS10-11G>A among this population has also been demonstrated in several other Mediterranean populations, including Spain, Italy, Greece, Turkey, and Palestinian, Moroccan, and other Jewish populations of the region (Kleiman et al., 1994) . It would be interesting to expand this study to an investigation of haplotypes to clarify the geographic and ethnic origin of the mutations and also assess genetic admixture, the effects of migration and expansion, and founder effects in this ethnic group. The unexpectedly high frequency of mutation P281L might be explained by consanguinity (five homozygous patients are from consanguineous families) and other factors such as genetic drift operating on this population. The L48S mutation reported to be common among Turks (13.3%) AV refers to the ''assigned value'' of individual mutations (Guldberg et al., 1998) , differentiating between mutations causing severe PKU (AV ¼ 1), moderate PKU (AV ¼ 2), mild PKU (AV ¼ 4), and mild hyperphenylalaninemia (MHP) (AV ¼ 8), when associated with null mutations.
PKU, phenylketonuria. (Aulehla-Scholz and Heilbronner, 2003) has an allelic frequency of null in our cohort. This indicates some differences between these two populations. This mutation is also less common in the other ethnic groups (Zschocke, 2003) . Some associations between mutations and polymorphisms were observed in this cohort. The IVS2þ5G>C mutation occurred on the same allele with the IVS2þ19T>C polymorphisms; similar results were previously reported in Egyptian and Brazilian patients (Hashem et al., 1996; Santana da Silva et al., 2003) . Associations between V245V polymorphism and R243X and E280K mutations have also been detected in Azeri Turk patients.
Exons 7 and 11 and their adjacent intronic regions carry 78% of the mutant alleles. To achieve an efficient detection strategy, specimens will be tested first for mutations in these regions and the DNA testing will be considered complete if at least two mutations are identified. The other exons and boundaries will be studied only when either one or no mutations are detected in the initial screen.
The applied experimental approach failed to reveal any PAH gene mutations in 14 PKU chromosomes (16%). In these cases, mutant chromosomes may harbor other defects in the PAH locus, such as large deletions and mutations in intronic sequences not analyzed by SSCP or in the regulatory regions.
In summary, the analysis of the PAH mutations causing PKU in Iranian Azeri Turkish patients further documented the molecular homogeneity of this disease. In addition, the mutation spectrum found in our cohort was somewhat different from those identified in patients from other ethnic origins, reflecting the unique population mixture of Iranian Azeri Turks. In addition, these findings may contribute to future genotype-phenotype correlations.
